Home
>
National Drug Code (NDC)
>
Sertraline
Sertraline - 54458-913-02 - (Sertraline)
Drug Information of Sertraline
| Product NDC: | 54458-913 |
| Proprietary Name: | Sertraline |
| Non Proprietary Name: | Sertraline |
| Active Ingredient(s): | 50 mg/1 & nbsp; Sertraline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sertraline
| Product NDC: | 54458-913 |
| Labeler Name: | International Labs, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077670 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120220 |
Package Information of Sertraline
| Package NDC: | 54458-913-02 |
| Package Description: | 30 TABLET in 1 PACKAGE (54458-913-02) |
NDC Information of Sertraline
| NDC Code | 54458-913-02 |
| Proprietary Name | Sertraline |
| Package Description | 30 TABLET in 1 PACKAGE (54458-913-02) |
| Product NDC | 54458-913 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sertraline |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120220 |
| Marketing Category Name | ANDA |
| Labeler Name | International Labs, Inc. |
| Substance Name | SERTRALINE HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
